AGA ROME LECTURESHIP 2021- 2025

Intersecting Pathways: Exploring the Clinical and Pathophysiological overlap between IBS and IBD?
Maura Corsetti, MD, PHD

Clinical Challenges and Management strategies: addressing the overlap of IBS & IBD?
Charles Bernstein, MD

What is the evidence of gut microbiota testing?
Andrea Shin, MD, MSCR

What is the evidence for food sensitivity testing?
Stephen Vanner, MD, MSCR

What are the relationships between diets and gut microbiome and their impact on symptoms?
Magnus Simrén, MD, PhD

Mechanistic Evidence for Altered Intestinal Permeability in Food Sensitivities, Functional Dyspepsia, and IBS
Madhusan Grover, MD, AGAF

Can we Measure Intestinal Permeability in Clinical Research and Practice?
Tim Vanuytsel, MD, PhD

Implications of Targeting Intestinal Permeability on Clinical Symptoms and Potential Treatments for DGBI
Lin Chang, MD

Post-COVID IBS and other DGBI: Prevalence, Incidence and Symptom Impact
Giovanni Barbara, MD

Psychosocial impact of COVID in Patients with DGBI
Sarah Ballou, PhD

Endocannabinoid System and Its Mechanistic Role In Nausea and Vomiting and Chronic Abdominal Pain
Keith A Sharkey, PhD, CAGF

Beneficial and Adverse Effects of Cannabinoids on Functional GI Disorders and Symptoms
Thangam Venkatesan, MD

AGA – Rome Annual Lectureship Series